Your results for

Filter by

Filter by
Results

Filter by

Content type
Key content topics
Key audience
Top cancer treatments

Proton beam therapy for liver cancers.

03/02/2020
/ Publications
/
Dosimetry
Toxicity

A review article examined the latest utilization of PBT for hepatocellular carcinoma and cholangiocarcinoma, as well as liver metastasis. The dosimetric...

Early and late side effects, dosimetric parameters and QoL after PBT and IMRT for prostate cancer

03/03/2019
/ Publications
/
Dosimetry

A study by the researchers of Dresden and Heidelberg. Eighty-eight patients with localized prostate cancer treated with PBT (31) or IMRT (57) were matched using...

Proton Therapy for Prostate Cancer

11/09/2018
/ Publications
/
Dosimetry
Clinical Trial

A review examined the dosimetric rationale and theoretical benefit of proton radiation for prostate cancer and the current state of the clinical evidence for...

Finding Value for Protons: The Case of Prostate Cancer?

05/04/2018
/ Publications
/
Dosimetry
Quality of life

A review by UPenn examined the dosimetric data and clinical outcome reports. Clinical studies largely suggest no difference in urinary side effects or erectile...

Does Proton Therapy Offer Demonstrable Clinical Advantages for Treating Thoracic Tumors?

04/04/2018
/ Publications
/
Dosimetry

A review by the MD Anderson group examined the available data with regard to proton therapy for thoracic malignancies, and presented the unique challenges in...

Executive Summary of Clinical and Technical Guidelines for Esophageal Cancer Proton Beam Therapy From the Particle Therapy Co-Operative Group Thoracic and Gastrointestinal Subcommittees.

10/10/2021
/ Publications
/
Dosimetry
Reirradiation
Motion Management

 In this guideline document, the dosimetric data and clinical evidence of PBT for esophageal cancer (EC) was summarized and evaluated. The clinical outcome data...

Treating gastrointestinal malignancy with proton therapy

01/10/2016
/ White Paper
/
Toxicity
Dosimetry
Chemotherapy

The improved dosimetry with proton therapy enables greater sparing of normal tissues and...

Proton Beam Therapy versus Photon Radiotherapy for Stage I Non-Small Cell Lung Cancer.

13/09/2022
/ Publications
/
Dosimetry

Published by the NCC group, Korea, this study reported clinical outcomes and dosimetry comparison of 289 patients with stage I NSCLC treated with protons (n=112...

Long-term outcomes of high-dose (74 GyE) proton beam therapy with concurrent chemotherapy for stage III nonsmall-cell lung cancer.

14/05/2021
/ Publications
/
Dosimetry
Toxicity

This study reported outcomes of 45 patients with stage III NSCLC treated with PBT of 74 GyE and concurrent chemotherapy. With a median follow-up time of 42.1...

Exposure of the heart in lung cancer radiation therapy: A systematic review of heart doses published during 2013 to 2020.

01/07/2022
/ Publications
/
Dosimetry
IMRT
Motion Management

Data of 140 dosimetry studies was analyzed. In the 105 non-SABR studies, the average MHD was similar between IMRT and 3DCRT (10.9 Gy versus 10.6 Gy) and lower...